Therapeutically active anthranilic acid derivatives of Formula (I), processes for the preparation of said derivatives, pharmaceutical formulations containing the compounds and the use of the compounds in therapy, particularly in the treatment of diseases in which under-activation of the HM74A receptor contributes to the disease or in which activation of the receptor will be beneficial, are disclosed.
本文披露了公式(I)的治疗活性
蒽酸衍
生物,制备该衍
生物的过程,含有该化合物的制药配方以及化合物在治疗中的使用,特别是在治疗HM74A受体欠活化导致疾病或激活该受体将有益的疾病中的使用。